Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. Company
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-27 pm EST
253.65 USD   -0.48%
01/27Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl
DJ
01/26Amgen announces webcast of 2022 fourth quarter and full year financial results
PR
01/26Warren tells FTC she is "particularly concerned" about Amgen and Indivior deals
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:

- drug sales (93.5%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;

- other (6.5%): primarily royalties.

The United States account for 66.5% of net sales.

Number of employees : 24 200 people.
Sales per Business
20202021Delta
Human Therapeutics24 240.0095.3%24 297.0093.5% +0.24%
Other1 184.004.7%1 682.006.5% +42.06%
USD in Million
Sales per region
20202021Delta
United States18 496.0072.8%18 194.0070% -1.63%
Rest of the World6 787.0026.7%7 672.0029.5% +13.04%
Canada141.000.6%113.000.4% -19.86%
USD in Million
Managers
Name Title Age Since
Robert Bradway Chairman, President & Chief Executive Officer 59 -
Peter Griffith Chief Financial Officer & Executive Vice President 63 2020
David Reese Senior VP-Translational Sciences & Oncology 59 2017
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical - 2018
Mike Zahigian Chief Information Officer & Senior Vice President - 2017
Esteban Santos Senior Vice President-Manufacturing 54 2013
Nancy Grygiel Vice President-Compliance 54 2015
Arvind K. Sood Vice President-Investor Relations - 2004
Jonathan P. Graham Secretary, Executive VP & General Counsel 61 2019
Susan Sweeney Senior VP-Global Marketing, Access & Capabilities - 2019
Members of the board
Name Title Age Since
Robert Bradway Chairman, President & Chief Executive Officer 59 -
Ronald Sugar Independent Director 73 2011
Tyler E. Jacks, Dr. Independent Director 61 2012
Robert Eckert Lead Independent Director 67 2012
Greg Garland Independent Director 64 2013
Robert Sanders Williams, Dr. Independent Director 73 2014
Ellen Kullman Independent Director 66 2016
Charles M. Holley Independent Director 65 2017
Wanda M. Austin, Dr. Independent Director 67 2017
Brian J. Druker, Dr. Independent Director 66 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 533,579,206 532,474,452 99.8% 0 0.0% 99.8%
Shareholders
NameEquities%
Capital Research & Management Co. 71,504,200 13.4%
The Vanguard Group, Inc. 45,190,910 8.47%
SSgA Funds Management, Inc. 29,073,061 5.45%
PRIMECAP Management Co. 15,564,870 2.92%
Capital Research & Management Co. (Global Investors) 12,605,265 2.36%
NWQ Investment Management Co. LLC 11,762,842 2.20%
BlackRock Fund Advisors 11,674,835 2.19%
Geode Capital Management LLC 11,200,793 2.10%
Charles Schwab Investment Management, Inc. 9,236,530 1.73%
Smith Barney Asset Management 8,448,585 1.58%
Holdings
NameEquities%Valuation
BEIGENE, LTD. (6160) 246,269,426 18.2% 4,234,410,690 USD
FRAZIER LIFESCIENCES ACQUISITION CORPORATION (NAMS) 4,910,000 6.02% 53,519,000 USD
IMAGO BIOSCIENCES, INC. 1,193,047 3.53% 42,890,040 USD
VIGIL NEUROSCIENCE, INC. (VIGL) 3,206,281 9.01% 40,078,513 USD
JASPER THERAPEUTICS, INC. (JSPR) 2,700,000 7.28% 1,304,100 USD
Markets and indexes
- International Market
- DJIA / Nasdaq 100, S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200
Company contact information
Amgen Inc.
1 Amgen Center Drive
CA 91320-1799 Thousand Oaks, California

Phone : +1 805 447 1000
Fax : +1 805 447 1010
web site : https://investors.amgen.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Amgen Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
AMGEN INC.-3.42%135 342
JOHNSON & JOHNSON-4.77%439 835
ELI LILLY AND COMPANY-4.87%325 056
NOVO NORDISK A/S1.06%312 363
ROCHE HOLDING AG-0.40%277 685
MERCK & CO., INC.-5.02%267 180
ABBVIE INC.-9.49%258 606
PFIZER, INC.-13.64%245 807
ASTRAZENECA PLC-5.31%203 823
NOVARTIS AG-1.21%192 852
BRISTOL-MYERS SQUIBB COMPANY1.45%160 813
SANOFI-0.32%121 261
GILEAD SCIENCES, INC.-2.47%105 018
GSK PLC-1.92%70 897
DAIICHI SANKYO CO., LTD.2.00%63 966
BAYER AG16.46%60 020
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.56%49 468
CHUGAI PHARMACEUTICAL CO., LTD2.26%43 608
JIANGSU HENGRUI MEDICINE CO., LTD.13.00%40 937
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD10.16%28 263
ASTELLAS PHARMA INC.-3.39%27 195